FitLife Brands (FTLF) Competitors

$9.43 -0.22 (-2.28%)

Closing price 04:00 PM Eastern

Extended Trading

$9.44 +0.01 (+0.05%)

As of 04:13 PM Eastern

FTLF vs. ALT, IMRX, SNDL, EOLS, and SLN

Should you be buying FitLife Brands stock or one of its competitors? The main competitors of FitLife Brands include Altimmune (ALT), Immuneering (IMRX), SNDL (SNDL), Evolus (EOLS), and Silence Therapeutics (SLN). These companies are all part of the "pharmaceutical products" industry.

How does FitLife Brands compare to Altimmune?

FitLife Brands (NASDAQ:FTLF) and Altimmune (NASDAQ:ALT) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, media sentiment, analyst recommendations, dividends, earnings and institutional ownership.

: FitLife Brands has a net margin of 7.77% compared to Altimmune's net margin of -214,860.98%. FitLife Brands' return on equity of 19.75% beat Altimmune's return on equity.
Company Net Margins Return on Equity Return on Assets
FitLife Brands 7.77% 19.75% 9.57%
Altimmune -214,860.98% -49.35% -41.65%
: FitLife Brands has higher revenue and earnings than Altimmune. Altimmune is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
FitLife Brands $81.46M 1.09 $6.33M $0.63 14.97
Altimmune $41K 9,710.28 -$88.09M -$1.01 N/A
: 2.3% of FitLife Brands shares are held by institutional investors. Comparatively, 78.1% of Altimmune shares are held by institutional investors. 61.4% of FitLife Brands shares are held by insiders. Comparatively, 1.6% of Altimmune shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
: FitLife Brands has a beta of -0.01, suggesting that its stock price is 101% less volatile than the S&P 500. Comparatively, Altimmune has a beta of 0.18, suggesting that its stock price is 82% less volatile than the S&P 500.
: FitLife Brands presently has a consensus price target of $21.50, indicating a potential upside of 128.00%. Altimmune has a consensus price target of $18.00, indicating a potential upside of 488.24%. Given Altimmune's stronger consensus rating and higher possible upside, analysts clearly believe Altimmune is more favorable than FitLife Brands.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
FitLife Brands
1 Sell rating(s)
1 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.25
Altimmune
2 Sell rating(s)

1 Hold rating(s)

7 Buy rating(s)

0 Strong Buy rating(s)
2.50
: In the previous week, FitLife Brands had 1 more articles in the media than Altimmune. MarketBeat recorded 2 mentions for FitLife Brands and 1 mentions for Altimmune. FitLife Brands' average media sentiment score of 1.40 beat Altimmune's score of 0.00 indicating that FitLife Brands is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
FitLife Brands
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Altimmune
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company	Net Margins	Return on Equity	Return on Assets
FitLife Brands	7.77%	19.75%	9.57%
Altimmune	-214,860.98%	-49.35%	-41.65%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FitLife Brands	$81.46M	1.09	$6.33M	$0.63	14.97
Altimmune	$41K	9,710.28	-$88.09M	-$1.01	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FitLife Brands	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Altimmune	2 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
FitLife Brands	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Altimmune	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

FitLife Brands beats Altimmune on 10 of the 16 factors compared between the two stocks.

How does FitLife Brands compare to Immuneering?

FitLife Brands (NASDAQ:FTLF) and Immuneering (NASDAQ:IMRX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, dividends, earnings, institutional ownership and profitability.

: In the previous week, FitLife Brands had 2 more articles in the media than Immuneering. MarketBeat recorded 2 mentions for FitLife Brands and 0 mentions for Immuneering. FitLife Brands' average media sentiment score of 1.40 beat Immuneering's score of 0.00 indicating that FitLife Brands is being referred to more favorably in the media.
Company Overall Sentiment
FitLife Brands Positive
Immuneering Neutral
: FitLife Brands presently has a consensus price target of $21.50, indicating a potential upside of 128.00%. Immuneering has a consensus price target of $16.50, indicating a potential upside of 208.99%. Given Immuneering's stronger consensus rating and higher probable upside, analysts clearly believe Immuneering is more favorable than FitLife Brands.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
FitLife Brands
1 Sell rating(s)
1 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.25
Immuneering
1 Sell rating(s)

0 Hold rating(s)

5 Buy rating(s)

1 Strong Buy rating(s)
2.86
: FitLife Brands has a beta of -0.01, suggesting that its share price is 101% less volatile than the S&P 500. Comparatively, Immuneering has a beta of 0.37, suggesting that its share price is 63% less volatile than the S&P 500.
: 2.3% of FitLife Brands shares are held by institutional investors. Comparatively, 67.7% of Immuneering shares are held by institutional investors. 61.4% of FitLife Brands shares are held by company insiders. Comparatively, 22.9% of Immuneering shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
: FitLife Brands has a net margin of 7.77% compared to Immuneering's net margin of 0.00%. FitLife Brands' return on equity of 19.75% beat Immuneering's return on equity.
Company Net Margins Return on Equity Return on Assets
FitLife Brands 7.77% 19.75% 9.57%
Immuneering N/A -43.33% -39.75%
: FitLife Brands has higher revenue and earnings than Immuneering. Immuneering is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
FitLife Brands $81.46M 1.09 $6.33M $0.63 14.97
Immuneering N/A N/A -$56.03M -$1.38 N/A

Company	Overall Sentiment
FitLife Brands	Positive
Immuneering	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FitLife Brands	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Immuneering	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.86

Company	Net Margins	Return on Equity	Return on Assets
FitLife Brands	7.77%	19.75%	9.57%
Immuneering	N/A	-43.33%	-39.75%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FitLife Brands	$81.46M	1.09	$6.33M	$0.63	14.97
Immuneering	N/A	N/A	-$56.03M	-$1.38	N/A

Summary

FitLife Brands beats Immuneering on 10 of the 16 factors compared between the two stocks.

How does FitLife Brands compare to SNDL?

SNDL (NASDAQ:SNDL) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, profitability, dividends, analyst recommendations, institutional ownership and media sentiment.

: In the previous week, SNDL had 15 more articles in the media than FitLife Brands. MarketBeat recorded 17 mentions for SNDL and 2 mentions for FitLife Brands. FitLife Brands' average media sentiment score of 1.40 beat SNDL's score of 0.22 indicating that FitLife Brands is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SNDL
2 Very Positive mention(s)
5 Positive mention(s)
5 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Neutral
FitLife Brands
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
: SNDL currently has a consensus price target of $5.00, indicating a potential upside of 249.65%. FitLife Brands has a consensus price target of $21.50, indicating a potential upside of 128.00%. Given SNDL's higher probable upside, research analysts clearly believe SNDL is more favorable than FitLife Brands.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SNDL
2 Sell rating(s)
0 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
1.67
FitLife Brands
1 Sell rating(s)

1 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.25
: SNDL has a beta of 0.88, suggesting that its share price is 12% less volatile than the S&P 500. Comparatively, FitLife Brands has a beta of -0.01, suggesting that its share price is 101% less volatile than the S&P 500.
: 2.3% of FitLife Brands shares are owned by institutional investors. 61.4% of FitLife Brands shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
: FitLife Brands has a net margin of 7.77% compared to SNDL's net margin of -1.19%. FitLife Brands' return on equity of 19.75% beat SNDL's return on equity.
Company Net Margins Return on Equity Return on Assets
SNDL -1.19% -1.02% -0.85%
FitLife Brands 7.77% 19.75% 9.57%
: FitLife Brands has lower revenue, but higher earnings than SNDL. SNDL is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
SNDL $677.32M 0.54 -$11.29M -$0.03 N/A
FitLife Brands $81.46M 1.09 $6.33M $0.63 14.97

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SNDL	2 Very Positive mention(s)	5 Positive mention(s)	5 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Neutral
FitLife Brands	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SNDL	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67
FitLife Brands	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Company	Net Margins	Return on Equity	Return on Assets
SNDL	-1.19%	-1.02%	-0.85%
FitLife Brands	7.77%	19.75%	9.57%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SNDL	$677.32M	0.54	-$11.29M	-$0.03	N/A
FitLife Brands	$81.46M	1.09	$6.33M	$0.63	14.97

Summary

FitLife Brands beats SNDL on 12 of the 16 factors compared between the two stocks.

How does FitLife Brands compare to Evolus?

Evolus (NASDAQ:EOLS) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

: FitLife Brands has a net margin of 7.77% compared to Evolus' net margin of -17.38%. FitLife Brands' return on equity of 19.75% beat Evolus' return on equity.
Company Net Margins Return on Equity Return on Assets
Evolus -17.38% N/A -21.57%
FitLife Brands 7.77% 19.75% 9.57%
: 90.7% of Evolus shares are owned by institutional investors. Comparatively, 2.3% of FitLife Brands shares are owned by institutional investors. 5.9% of Evolus shares are owned by insiders. Comparatively, 61.4% of FitLife Brands shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
: FitLife Brands has lower revenue, but higher earnings than Evolus. Evolus is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Evolus $297.18M 1.39 -$51.64M -$0.81 N/A
FitLife Brands $81.46M 1.09 $6.33M $0.63 14.97
: Evolus has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500. Comparatively, FitLife Brands has a beta of -0.01, suggesting that its share price is 101% less volatile than the S&P 500.
: In the previous week, Evolus had 9 more articles in the media than FitLife Brands. MarketBeat recorded 11 mentions for Evolus and 2 mentions for FitLife Brands. FitLife Brands' average media sentiment score of 1.40 beat Evolus' score of -0.11 indicating that FitLife Brands is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Evolus
2 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
FitLife Brands
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
: Evolus currently has a consensus price target of $16.00, indicating a potential upside of 151.57%. FitLife Brands has a consensus price target of $21.50, indicating a potential upside of 128.00%. Given Evolus' stronger consensus rating and higher possible upside, analysts clearly believe Evolus is more favorable than FitLife Brands.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Evolus
1 Sell rating(s)
1 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.50
FitLife Brands
1 Sell rating(s)

1 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.25

Company	Net Margins	Return on Equity	Return on Assets
Evolus	-17.38%	N/A	-21.57%
FitLife Brands	7.77%	19.75%	9.57%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evolus	$297.18M	1.39	-$51.64M	-$0.81	N/A
FitLife Brands	$81.46M	1.09	$6.33M	$0.63	14.97

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Evolus	2 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
FitLife Brands	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evolus	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
FitLife Brands	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Summary

Evolus and FitLife Brands tied by winning 8 of the 16 factors compared between the two stocks.

How does FitLife Brands compare to Silence Therapeutics?

FitLife Brands (NASDAQ:FTLF) and Silence Therapeutics (NASDAQ:SLN) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings.

: 2.3% of FitLife Brands shares are held by institutional investors. Comparatively, 98.7% of Silence Therapeutics shares are held by institutional investors. 61.4% of FitLife Brands shares are held by company insiders. Comparatively, 4.1% of Silence Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
: In the previous week, FitLife Brands and FitLife Brands both had 2 articles in the media. FitLife Brands' average media sentiment score of 1.40 beat Silence Therapeutics' score of 0.99 indicating that FitLife Brands is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
FitLife Brands
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Silence Therapeutics
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
: FitLife Brands has higher revenue and earnings than Silence Therapeutics. Silence Therapeutics is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
FitLife Brands $81.46M 1.09 $6.33M $0.63 14.97
Silence Therapeutics $560K 602.18 -$88.61M -$1.87 N/A
: FitLife Brands presently has a consensus price target of $21.50, indicating a potential upside of 128.00%. Silence Therapeutics has a consensus price target of $34.50, indicating a potential upside of 383.19%. Given Silence Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Silence Therapeutics is more favorable than FitLife Brands.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
FitLife Brands
1 Sell rating(s)
1 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.25
Silence Therapeutics
2 Sell rating(s)

0 Hold rating(s)

4 Buy rating(s)

1 Strong Buy rating(s)
2.57
: FitLife Brands has a beta of -0.01, indicating that its share price is 101% less volatile than the S&P 500. Comparatively, Silence Therapeutics has a beta of 1.52, indicating that its share price is 52% more volatile than the S&P 500.
: FitLife Brands has a net margin of 7.77% compared to Silence Therapeutics' net margin of -15,851.88%. FitLife Brands' return on equity of 19.75% beat Silence Therapeutics' return on equity.
Company Net Margins Return on Equity Return on Assets
FitLife Brands 7.77% 19.75% 9.57%
Silence Therapeutics -15,851.88% -101.71% -55.53%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
FitLife Brands	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Silence Therapeutics	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FitLife Brands	$81.46M	1.09	$6.33M	$0.63	14.97
Silence Therapeutics	$560K	602.18	-$88.61M	-$1.87	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FitLife Brands	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Silence Therapeutics	2 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.57

Company	Net Margins	Return on Equity	Return on Assets
FitLife Brands	7.77%	19.75%	9.57%
Silence Therapeutics	-15,851.88%	-101.71%	-55.53%

Summary

FitLife Brands beats Silence Therapeutics on 9 of the 16 factors compared between the two stocks.

Get FitLife Brands News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FTLF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FTLF vs. The Competition

Export

Metric	FitLife Brands	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$88.56M	$8.14B	$6.25B	$11.87B
Dividend Yield	N/A	2.45%	2.73%	5.21%
P/E Ratio	14.87	119.73	29.04	28.47
Price / Sales	1.09	7.42	476.61	60.92
Price / Cash	7.96	17.32	27.62	36.52
Price / Book	2.03	3.52	9.67	6.67
Net Income	$6.33M	$223.69M	$3.55B	$332.53M
7 Day Performance	1.84%	0.07%	1.70%	2.01%
1 Month Performance	-11.12%	10.32%	5.62%	9.19%
1 Year Performance	-39.12%	0.92%	34.41%	39.59%

FitLife Brands Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FTLF FitLife Brands	4.7434 of 5 stars	$9.43 -2.3%	$21.50 +128.0%	N/A	$88.56M	$81.46M	14.87	20	Positive News
ALT Altimmune	2.9171 of 5 stars	$2.63 -4.0%	$18.00 +584.4%	N/A	$342.18M	$41K	N/A	50	Positive News Upcoming Earnings
IMRX Immuneering	1.937 of 5 stars	$5.25 +0.4%	$16.50 +214.3%	N/A	$339.68M	N/A	N/A	60
SNDL SNDL	3.0689 of 5 stars	$1.32 -10.5%	$5.00 +280.2%	N/A	$338.48M	$946.40M	N/A	2,751	High Trading Volume
EOLS Evolus	2.0713 of 5 stars	$5.18 -1.7%	$16.00 +208.9%	N/A	$337.01M	$297.18M	N/A	170	Trending News Earnings Report Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:FTLF) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FitLife Brands (FTLF) Competitors

FTLF vs. ALT, IMRX, SNDL, EOLS, and SLN

How does FitLife Brands compare to Altimmune?

Summary

How does FitLife Brands compare to Immuneering?

Summary

How does FitLife Brands compare to SNDL?

Summary

How does FitLife Brands compare to Evolus?

Summary

How does FitLife Brands compare to Silence Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FTLF vs. The Competition

FitLife Brands Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

FitLife Brands (FTLF) Competitors

FTLF vs. ALT, IMRX, SNDL, EOLS, and SLN

How does FitLife Brands compare to Altimmune?

Summary

How does FitLife Brands compare to Immuneering?

Summary

How does FitLife Brands compare to SNDL?

Summary

How does FitLife Brands compare to Evolus?

Summary

How does FitLife Brands compare to Silence Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FTLF vs. The Competition

FitLife Brands Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools